NovaBay Pharmaceuticals, Inc. (NBY)' Neutrophase Is Focus Of Dr. John Crew's Presentation At Advanced Wound Care Symposium
4/24/2014 7:25:11 AM
NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a clinical-stage biopharmaceutical company developing topical non-antibiotic anti-microbial products, today announced that Dr. John R. Crew, Medical Director of the Advanced Wound Care Center at Seton Medical Center in Daly City, California, will present at the Spring Symposium on Advanced Wound Care. Dr. Crew will explain to the doctors attending the meeting that NovaBay’s NeutroPhase® Advanced Wound Cleanser offers a significant advance in the treatment of flesh-eating infections.
Help employers find you! Check out all the jobs and post your resume.
comments powered by